XML 93 R20.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Financial Instruments | 12 Months Ended
--- | ---
Dec. 31, 2013
Investments, All Other Investments [Abstract] |
Financial Instruments Disclosure [Text Block] | 14. Financial Instruments The following table sets forth the financial instruments as of December 31, 2013 and 2012, that the Company measured at fair value, on a recurring basis by level, within the fair value hierarchy (in thousands). As required by the standard, assets measured at fair value are classified in their entirety based on the lowest level of input that is significant to their fair value measurement.
December 31, 2013 |  | Level 1 |  | Level 2 |  | Level 3 |
Liability |  |  |  |  |  |  |  |  |  |
Derivatives |  | $ | — |  | $ | 577 |  | $ | — |
December 31, 2012 |  | Level 1 |  | Level 2 |  | Level 3 |
Assets |  |  |  |  |  |  |  |  |  |
Derivatives |  | $ | — |  | $ | 125 |  | $ | — |
The Level 2 assets contain foreign currency forward contracts. Fair value is determined based on the observable market transactions of spot and forward rates. The fair value of these contracts as of December 31, 2013 is included in accrued expenses and fair value as of December 31, 2012 is included in prepaid expenses and other current assets in the accompanying consolidated balance sheets.
The Synodex subsidiary of the IADS segment has not achieved significant revenue to date and has incurred losses since inception. As a result in the third quarter of 2013, the Company evaluated the carrying value of the fixed assets of its Synodex subsidiary compared to its fair value and concluded that that the carrying value exceeds its fair value. This resulted in an impairment charge of $5.5 million for the year ended December 31, 2013. The fixed assets were measured at fair value on a nonrecurring basis using significant unobservable inputs (Level 3).

X
- Definition The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures. + References No definition available. + Details
Name: | us-gaap_FinancialInstrumentsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_InvestmentsAllOtherInvestmentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration